Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients

BACKGROUND: The purpose of this phase II study was to evaluate the safety and efficacy of weekly irinotecan and capecitabine (wXELIRI) treatment in patients with metastatic colorectal cancer, specifically the rate of severe diarrhea. METHODS: Patients with unresectable histologically confirmed metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenhua, Xu, Jianming, Shen, Lin, Liu, Tianshu, Guo, Weijian, Zhang, Wen, Chen, Zhiyu, Zhu, Xiaodong, Li, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300831/
https://www.ncbi.nlm.nih.gov/pubmed/25527007
http://dx.doi.org/10.1186/1471-2407-14-986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300831/
https://www.ncbi.nlm.nih.gov/pubmed/25527007
http://dx.doi.org/10.1186/1471-2407-14-986

Ejemplares similares